Immunotherapeutic implications of IL-6 blockade for cytokine storm.
about
Photodynamic antimicrobial chemotherapy with the novel amino acid-porphyrin conjugate 4I: In vitro and in vivo studies.Blockade of interleukin-6 receptor in the periphery promotes rapid and sustained antidepressant actions: a possible role of gut-microbiota-brain axisHLA-E inhibitor enhances the killing of neuroblastoma stem cells by co-cultured dendritic cells and cytokine-induced killer cells loaded with membrane-based microparticlesThe role and therapeutic targeting of IL-6 in rheumatoid arthritis.Roles of IL-6 in Ocular Inflammation: A Review.Plasma Cytokines and Chemokines in Zambian Children With Measles: Innate Responses and Association With HIV-1 Coinfection and In-Hospital Mortality.Bortezomib treatment induces a higher mortality rate in lupus model mice with a higher disease activity.Interleukin-6 as a biomarker for asthma: hype or is there something else?"Neurological complications of new chemotherapy agents".Using IL-6 concentrations in the first 24 h following trauma to predict immunological complications and mortality in trauma patients: a meta-analysis.Effect of Continuous Digital Hypothermia on Lamellar Inflammatory Signaling When Applied at a Clinically-Relevant Timepoint in the Oligofructose Laminitis Model.Understanding cytokine release syndrome.Hepatic Natural Killer T-cell and CD8+ T-cell Signatures in Mice with Nonalcoholic Steatohepatitis.Pharmacological inhibition of IL-6 trans-signaling improves compromised fracture healing after severe trauma.Anaphylaxis in the 21st century: phenotypes, endotypes, and biomarkers.Cytokine release syndrome.The clinical importance of a cytokine network in the acute phase of sepsisThe biological basis and clinical symptoms of CAR-T therapy-associated toxicites
P2860
Q33663536-0CA83219-2361-4F12-B9B3-751DACDA7C60Q34557243-B24A3333-301E-403D-9D12-227CD7B6FA8FQ37680008-9EACEDE7-A995-4677-9859-D4CD49485241Q38685086-C12BD282-CA29-41FF-8AA2-8CFE41B740A3Q38986592-8FD2ED92-56D9-4CA3-A16E-0E6BC191ED37Q40359541-EA8CADAB-B056-4F24-A8B9-D65F1EABB88CQ41363502-77FCA70F-6C9B-48E2-A351-9DEDFF6022EEQ41641219-16A0595F-C268-4077-9A2E-60CE4B7832A2Q45069581-8EF6DCC4-C2B8-43FD-84AD-C083595B9AC0Q47594890-E104FC80-401A-40AE-9A09-94896BACE0B5Q47739222-2267C30B-998B-4233-8868-946FA28791B0Q48278608-7743DB30-5F38-4FAC-944B-15FD612DE0C9Q55035260-7CE8BE7A-CFE4-4DA4-9A39-875B65786BC1Q55098015-07D238DC-9E1C-4732-A37E-56A65EEA2909Q55374006-C2665B8E-0E55-4EF5-BE02-83124A282915Q55438228-2C0F2C6A-3624-4718-9E56-D331946F612FQ58726835-7F559667-6545-42ED-9A4B-E6722898B0C3Q58765358-A68F0816-D3E3-4CA5-8560-0D97E8B61288
P2860
Immunotherapeutic implications of IL-6 blockade for cytokine storm.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Immunotherapeutic implications of IL-6 blockade for cytokine storm.
@en
type
label
Immunotherapeutic implications of IL-6 blockade for cytokine storm.
@en
prefLabel
Immunotherapeutic implications of IL-6 blockade for cytokine storm.
@en
P2860
P356
P1433
P1476
Immunotherapeutic implications of IL-6 blockade for cytokine storm
@en
P2093
Tadamitsu Kishimoto
Toshio Tanaka
P2860
P304
P356
10.2217/IMT-2016-0020
P577
2016-07-01T00:00:00Z